CEL-SCI

YTD

ALL

Why Robinhood?

You can watch CEL-SCI and buy or sell other stocks, ETFs, and their options commission-free!

About CVM+

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS).

CEO

Geert R. Kersten, MBA

CEOGeert R. Kersten, MBA

Employees

—

Employees—

Headquarters

Vienna, Virginia

HeadquartersVienna, Virginia

Founded

1983

Founded1983

Employees

—

Employees—

CVM+ Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.